Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults
NEJM Evidence (2022) - Comments
doi: 10.1056/evidoa2100043  issn: 2766-5526 

Yoseph Caraco, Gordon E. Crofoot, Pablo Andres Moncada, Anna Nikolaevna Galustyan, Dany Badibanga Musungaie, Brendan Payne, Evgeniy Kovalchuk, Antonio Gonzalez, Michelle L. Brown, Angela Williams-Diaz, Wei Gao, Julie M. Strizki, Jay Grobler, Jiejun Du, Christopher A. Assaid, Amanda Paschke, Joan R. Butterton, Matthew G. Johnson, Carisa De Anda